Navigation Links
Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
Date:3/31/2008

MONMOUTH JUNCTION, N.J., March 31 /PRNewswire/ -- Transave Inc. reported today that its lead product candidate, ARIKACE(TM) (liposomal amikacin for inhalation), may have the ability to penetrate mucus and biofilms, and decrease the number of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis, according to results of a study published in the Journal of Antimicrobial Chemotherapy.

Results of the study titled "Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomanas aeruginosa lung infections," were published in the April issue of the journal. Transave is a biopharmaceutical company focused on the development of next-generation liposomal drug products for inhalation.

ARIKACE is a form of the antibiotic amikacin, which is enclosed in nanocapsules of lipids called liposomes. The study evaluated the ability of the ARIKACE liposomes to pass through patient mucus (sputum) ex vivo and to penetrate the bacteria's biofilm barrier in an established flow-cell in vitro model. The biofilm is a gel-like matrix in the lungs formed by colonies of Pseudomonas that create a protective barrier for bacteria. This prevents patients with cystic fibrosis (CF) from clearing infections even under aggressive antibiotic treatment. It is not practical to observe biofilm interactions in humans; therefore, the Center for Biofilm Engineering at Montana State University has developed a model to microscopically visualize the penetration of liposomes into Pseudomonas biofilms.

Separate studies showed that the small, neutrally charged ARIKACE liposomes facilitated antibiotic passage through the patient mucus layer and penetration into the Pseudomonas biofilm. Prior studies have shown that free aminoglycosides bind to patient mucus and thus have reduced bioactivity in killing Pseudomonas. Using microscopic techniques, the investigators were able to see that Arikace liposomes effectively penetrated an
'/>"/>

SOURCE Transave Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Kline Study: Better Brushing Habits Boost European Oral Care Sales
4. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
5. NASA study will help stop stowaways to Mars
6. New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
7. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
8. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
9. Study Supports Use of GlycoMark Blood Test to Evaluate Therapy in Children with Diabetes
10. Quigley Corporation Releases Update on Quigley Pharmas Phase IIb Clinical Study of QR-333 in Diabetic Peripheral Neuropathy
11. Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Invisible Sentinel Inc., ... the food and beverage industries, announced today that ... under a non-exclusive agreement by Enartis, a global ... Enartis, an Esseco Group company headquartered in Trecate, ... California and other global markets for their own ...
(Date:9/22/2014)...  Neogen Corporation (Nasdaq: NEOG ) announced ... its 2015 fiscal year, which ended Aug. 31, was ... of $7,839,000 in the first quarter of last year. ... 2013, earnings per share in the current quarter were ... First quarter revenues increased 15% to $67,599,000, from the ...
(Date:9/22/2014)... 22, 2014  WIRB-Copernicus Group (WCG), the world,s ... for clinical research, announced today that its Western ... reaccredited by the Association for the Accreditation of ... improve safeguards for clinical research participants. ... , Ph.D., commented, "It is of utmost importance ...
(Date:9/22/2014)... 2014 METTLER TOLEDO is pleased ... measuring device CNS110 ScanTape™ . Replacing a ... offering greater ease and accuracy for transport and ... significantly enhance productivity—an important benefit for load planning ... equals profits. , Usable at any point ...
Breaking Biology Technology:Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 2Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally 3Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2ScanTape™ Handheld Dimensioner Increases Processing Volume 2
... living in Western,Oregon who suffer from the symptoms ... of out-patient, in-office treatment to cure the,problem. biolitec, ... of doctors in,Western Oregon is now offering its ... benign prostate hyperplasia (BPH),that quickly and gently eliminates ...
... Online highlighted during industry-leading event September 10 - 11, ... ... 5 Plexus Systems, Inc.,provider of Plexus Online on-demand software ... Technology Conference,September 10-11, 2008 at the San Jose McEnery Conference ...
... PARK, Ill., Sept. 5 Abbott (NYSE: ABT ... Conference on Friday,Sept. 12, 2008, in London. John B. ... on the company at 2 a.m. Central,time (8 a.m. ... presentation will be accessible through,Abbott,s Investor Relations Web site ...
Cached Biology Technology:Revolutionary New In-Office EVOLVE(R) Laser Prostate Treatment Available Throughout Western Oregon 2Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 2
(Date:9/22/2014)... fishes that manufacture their own "antifreeze" proteins to ... an unfortunate side effect, researchers report: The protein-bound ... melting even when temperatures warm. , The ... the National Academy of Sciences . , "We ... of the evolution of antifreeze proteins in Antarctic ...
(Date:9/22/2014)... CITY (September 22, 2014)The Brain & Behavior ... award of NARSAD Young Investigator Grants valued ... of the world,s most promising young scientists. ... groundbreaking neurobiological research will seek to identify ... for psychiatric disorders that affect one in ...
(Date:9/22/2014)... much more useful in homes, if they could locate ... world with cameras and lasers, which have difficulty reliably ... in clutter. A complementary way robots can "sense" what ... ultra-high frequency radio-frequency identification (UHF RFID) tags. Inexpensive self-adhesive ... robot to search a room for the correct tag,s ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3
... new study in the July 18 issue of The ... more harmful than their unpigmented relatives. A group of ... have discovered that the molecules that give certain bugs ... cells called neutrophils. , Scientists and clinicians have known ...
... Microbiologists seeking ways to eliminate pollution from waterways with ... in freshwater ponds can generate electricity. They present their ... American Society for Microbiology. , "The bacteria are capable ... used to operate small electronic devices. As long as ...
... of that group of diseases, affects 500 000 people in ... Leishmania infantum, transmitted by sand fly bites. There is no ... if no treatment is given. In the most heavily affected ... acts as parasite reservoir for humans. Development of a vaccine ...
Cached Biology News:Pollution-eating bacteria produce electricity 2Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 2Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 3Visceral Leishmaniasis: Successful Vaccine Trial In Dogs 4
...
...
... >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long been ... radiolabeled ligands selected to keep pace with ... of products and services for receptor research ... radioligands. If you do not find exactly ...
... TURBO DNase (patent pending) was developed using a ... into the DNA binding pocket of wild-type DNase ... the protein for DNA. The result is a ... for DNA, and an ability to maintain at ...
Biology Products: